News

A robust and efficient protein biomarker development pipeline helps scientists overcome common challenges associated with ...
A long-term study reveals how age, sex, genetics, and menopause influence blood biomarkers related to dementia. The study ...
New research from Cornell University suggests that dogs may hold the key to advancing treatments for one of the most stubborn ...
Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread screening, a Karolinska Institutet study finds. A new study published in ...
Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal ...
Interleukin-6 could help physicians diagnose sepsis early in children and pregnant women, according to a real-world study presented at the ESCMID Global meeting 2025.“Traditional biomarkers have a lag ...
Researchers have developed drug-delivering aptamers that can deliver a cytotoxic double punch to leukemic stem cells.
Beam Therapeutics Inc. (NASDAQ:BEAM) on Saturday presented additional data from the Phase 1/2 clinical trial of BEAM-302 in ...
Researchers used integrated Mendelian randomization in a cohort of over 247,000 individuals to identify 62 plasma proteins associated with breast cancer risk. Nine high-confidence targets, including ...
A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful ...